Cetera Investment Advisers
ORGO icon

Cetera Investment Advisers’s Organogenesis Holdings ORGO Stock Holding History

Cetera Investment Advisers’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-52,961
Closed -$223K – 4820
2025
Q3 		$223K Sell
52,961
-7,807
-13% -$36.3K ﹤0.01% 4078
2025
Q2 		$222K Buy
+60,768
New +$227K ﹤0.01% 3644
2022
Q2 		– Sell
-15,970
Closed -$122K – 1918
2022
Q1 		$122K Buy
+15,970
New +$124K ﹤0.01% 1783

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cetera Investment Advisers's ORGO Position: Q4 2025 in Review

Cetera Investment Advisers sold out of Organogenesis Holdings (ORGO) in Q4 2025, closing a stake of 52,961 shares — an estimated $223K sold.

Cetera Investment Advisers first reported a position in ORGO in Q1 2022 and held it in 3 quarters. The position peaked at $223K in Q3 2025. 147 funds tracked by Wall St. Rank hold ORGO as of Q4 2025.

  • Cetera Investment Advisers reported no remaining Organogenesis Holdings position as of Q4 2025 after selling out during the quarter.
  • Cetera Investment Advisers sold 52,961 Organogenesis Holdings shares in Q4 2025, an estimated $223K.
  • Cetera Investment Advisers first reported a position in Organogenesis Holdings in Q1 2022 and held it in 3 quarters.
  • Cetera Investment Advisers's Organogenesis Holdings position peaked at $223K in Q3 2025.
  • 147 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2025.

Based on Cetera Investment Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.